Dermatol. praxi. 2021;15(4):212-214 | DOI: 10.36290/der.2021.039
An update on antibiotic treatment in dermatology
- Antibiotické středisko, Centrum klinických laboratoří, Zdravotní ústav se sídlem v Ostravě
In their practice, dermatologists encounter a wide range of inflammatory diseases of the skin and subcutaneous tissue of infectious origin. Superficial bacterial skin infections are typically unaccompanied by general symptoms, and are most often treated on an outpatient basis by means of topical antimicrobial agents or oral systemic antibiotics. Skin and soft tissue infections with a more severe course are treated with intravenous broad-spectrum antibiotics during hospitalization. Distinct nosological entities are caused by typical agents, which guides the selection of antibiotic for targeted therapy. Currently, it is also important to consider the option of community-associated methicillin-resistant Staphylococcus aureus (MRSA), which usually tends to be associated with nosocomial infections. The article summarizes the current recommendations for antibiotic treatment of bacterial skin infections.
Keywords: skin infection, antibiotics, antibiotic resistance, antibiotic treatment.
Published: November 23, 2021 Show citation
References
- Moran GJ, Abrahamian FM, Lovecchio F, et al. Acute bacterial skin infections: developments since the 2005 Infectious Diseases Society of America (IDSA) guidelines. J Emerg Med. 2013; 44(6): e397-412. doi: 10.1016/j.jemermed.2012.11.050. Epub 2013 Mar 5. PMID: 23466022.
Go to original source... 
Go to PubMed... - Stevens DL, Bisno AL, Chambers HF, et al. Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases. 2014; 59(2): e10-e52. https://doi.org/10.1093/cid/ciu296. Go to original source... Go to PubMed...
- Sartelli M, Malangoni MA, May AK, et al. World Society of Emergency Surgery (WSES) guidelines for management of skin and soft tissue infections. World J Emerg Surg. 2014; 57(9). https://doi.org/10.1186/1749-7922-9-57. Go to original source... Go to PubMed...
- Gener G, Canoui-Poitrine F, Revuz JE, et al. Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients. Dermatology. 2009; 219(2): 148-154. doi: 10.1159/000228334. Epub 2009 Jul 8. PMID: 19590173. Go to original source... Go to PubMed...
- Scheinfeld N. Why rifampin (rifampicin) is a key component in the antibiotic treatment of hidradenitis suppurativa: a review of rifampin's effects on bacteria, bacterial biofilms, and the human immune system. Dermatol Online J. 2016; 22(6): 13030/qt85s8s1s8. PMID: 27617596. Go to original source...